Health Care

The largest U.S. pharmacy chain's results trailed forecasts as store traffic reversed.

New documents show the Obama administration was aware the SHOP insurance exchange needed to be delayed as early as August, but waited until Nov. 27 to announce the news.

FOX Business interviewed chief executives from GlaxoSmithKline, Humana, AthenaHealth and others at the second annual Forbes Healthcare Summit in New York City.

Deadlocked: The partial government shutdown could last weeks, leaving countless impacted businesses across the U.S. preparing for the worst.

A Chinese meat company's plan to buy U.S.-based Smithfield Foods has some lawmakers worried the deal could create food safety issues.

The drug maker's bottom line exceeded forecasts, but it suffered weaker-than-expected sales due to generic competition. 

President Obama addressed glitches with the Affordable Care Act's registration process since its rollout two weeks ago. 

The buyout carries a hefty premium of 85.5% and values the smaller medical-device maker at $1.65 billion.

Rite-Aid announced plans on Friday to issue a new $500 million second-lien term loan, and narrowed the high-end of its full-year guidance by a penny.

The generic drugmaker said it was in early stage discussions to buy the specialty pharmaceutical company Warner Chilcott.  

Pfizer’s board of directors approved an 8% increase in the drug maker’s quarterly dividend.

A new report suggests that sleep apnea may have contributed to the death of Supreme Court Justice Antonin Scalia.

Valeant Pharmaceuticals said it would restate its financial results for 2014 and 2015 after identifying some sales to Philidor that should have been recognized when products were dispensed to patients.

International Business Machines Corp said it would buy Truven Health Analytics, a provider of cloud-based healthcare data, for $2.6 billion, the company's fourth major health-related acquisition since launching the Watson Health unit in April last year.